Insider · CIK 0001851630
Graham Griffiths
Files at BRNS (Barinthus Biotherapeutics plc.). First filing -, latest -.
In brief
Graham Griffiths files SEC Form 4 as officer at BRNS (Barinthus Biotherapeutics plc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Graham Griffiths has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 3, 2025 | BRNS Barinthus Biotherapeutics plc. | AGrant or award Share Option (Right to Buy)derivative | +200,000 | $0.00 | $0 | 200,000 | Feb 5, 2025 |
Questions about Graham Griffiths
Answered from the filings on this page, as of the latest one.
Is Graham Griffiths buying or selling?
Graham Griffiths has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Graham Griffiths's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Graham Griffiths has 0.
Where does Graham Griffiths file Form 4?
Graham Griffiths has filed Form 4 at BRNS (Barinthus Biotherapeutics plc.) as Chief Business Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.